The Latest Breaking News on Pharma

Group will tackle potential restrictions to items such as medicine amid geopolitical and climate threats

There is a notable 100 per cent surge in medicine shortages compared to January 2022 as seen in the deteriorating health of patients across the UK.

The need for innovative healthcare solutions, personalized medicines and treatments, and the use of advanced technologies will propel the biotech industry forward. Amid this backdrop, let’s explore the investment potential of biotech stocks TG Therapeutics (TGTX), Galapagos (GLPG), BioMarin Pharmaceutical (BMRN), and United Therapeutics (UTHR).

Bayer remains undeterred by setbacks as they forge ahead with plans to expand in the US market, showing resilience and determination in the face of challenges.

Merck sets sail into new therapeutic waters with the 0 million acquisition of Harpoon Therapeutics, harnessing the power of innovation to navigate treat...

Revised Schedule M of Drugs and Cosmetics Rules, 1945 notified by Union Health Ministry to ensure robust quality control for pharma and biopharmaceutical products.

Get the latest on the FDA's decision to allow Florida to import medications from Canada, potentially reducing prescription costs for Americans. Learn about...

Thermo Fisher, an American biotech company, has halted sales of its DNA testing products in Tibet, amid concerns that its products might have assisted the Chinese government in a surveillance campaign in the ethnic region

State will be first to import drugs under federal program that Florida governor says could save consumers $150m in first year